18th Dec 2007 07:02
Advanced Medical Solutions Grp PLC18 December 2007 For Immediate Release 18 December 2007 Advanced Medical Solutions Group plc ("AMS" or "the Company") Trading Update Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the globalmedical technology company, today announces an update on current trading priorto its close period for the year to 31 December 2007. The Company's preliminaryresults will be announced in March 2008. Dr. Geoffrey Vernon, Chairman of Advanced Medical Solutions Group plc, stated: "The business has continued to make excellent progress during the second half ofthe year and I am pleased to report that the Group is trading at the top end ofmarket expectations for revenues, profitability and cash generation. The outlookremains positive with the business continuing to perform well across keyproducts and geographies." -ENDS- For further information, please contact: Advanced Medical Solutions Group plcDon Evans, Chief Executive OfficerMary Tavener, Finance Director Tel: +44 (0) 1606 545508www.admedsol.com Buchanan Communications Tel: +44 (0) 20 7466 5000Mark Court, Mary-Jane Johnson Landsbanki Securities (UK) Ltd Tel: +44 (0) 20 7426 9000Shaun Dobson / Xavier de Mol Notes to Editors: Advanced Medical Solutions is a leading company in the development andmanufacture of products for the $15 billion global woundcare market. Founded in 1991 and quoted on AIM, Advanced Medical Solutions is focused on thedesign, development and manufacture of innovative and technologically advancedproducts for woundcare and other medical applications. In-house natural and synthetic polymer technology is used to provide advancedwound dressings based on the moist healing principle. AMS's resources ensure aunique position as a vertically integrated 'one stop shop' to provide allcategories of moist wound healing products. The Company has the capability tomove a product from design and development through to production and deliveryready for distribution into customer markets. The acquisition of MedLogic in 2002 has brought AMS products and technology incyanoacrylate based tissue adhesives that offer benefits over sutures andstaples for closing topical wounds sold direct to hospitals or throughdistributors. AMS's technology and products currently serve the majority of the key globalmarkets and strategic partners. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Advanced Medical Solutions Group